Gemmell; Jack

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gemmell; Jack.The latest application filed is for "peptides effectife in the treatment of conditions requiring the removal or destruction of cells".

Company Profile

0.11.15

Gemmell; Jack - Mississauga CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptides Effectife In The Treatment Of Conditions Requiring The Removal Or Destruction Of Cells App 20150148303 - AVERBACK; Paul ; et al.	2015-05-28
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 8,716,247 - Averback , et al. May 6, 2	2014-05-06
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 8,569,446 - Averback , et al. October 29, 2	2013-10-29
Peptides Effective In The Treatment Of Tumors And Other Conditions Requiring The Removal Or Destruction Of Cells App 20130040900 - AVERBACK; PAUL ; et al.	2013-02-14
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 8,293,703 - Averback , et al. October 23, 2	2012-10-23
Peptides Effective In The Treatment Of Tumors And Other Conditions Requiring The Removal Or Destruction Of Cells App 20120114679 - Averback; Paul ; et al.	2012-05-10
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 8,067,378 - Averback , et al. November 29, 2	2011-11-29
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 7,745,572 - Averback , et al. June 29, 2	2010-06-29
Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells App 20090286742 - AVERBACK; PAUL ; et al.	2009-11-19
Protein and its use in diagnosing Alzheimer's disease Grant 7,544,771 - Averback , et al. June 9, 2	2009-06-09
Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells App 20090022743 - Averback; Paul ; et al.	2009-01-22
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 7,408,021 - Averback , et al. August 5, 2	2008-08-05
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells App 20080176805 - Averback; Paul ; et al.	2008-07-24
Humanized Antibody App 20080063598 - Averback; Paul ; et al.	2008-03-13
Peptides Effective In The Treatment Of Tumors And Other Conditions Requiring The Removal Or Destruction Of Cells App 20080027005 - Averback; Paul ; et al.	2008-01-31
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 7,317,077 - Averback , et al. January 8, 2	2008-01-08
Method of preventing or reducing the risk or incidence of cancer App 20070237780 - Averback; Paul ; et al.	2007-10-11
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 7,241,738 - Averback , et al. July 10, 2	2007-07-10
Protein and its use in diagnosing Alzheimer's disease App 20060188935 - Averback; Paul ; et al.	2006-08-24
Humanized antibody App 20050226883 - Averback, Paul ; et al.	2005-10-13
Peptides effective in the treatment of tumors and other conditions requiring the removal ordestruction of cells App 20050032704 - Averback, Paul ; et al.	2005-02-10
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells App 20030166569 - Averback, Paul ; et al.	2003-09-04
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells App 20030109437 - Averback, Paul ; et al.	2003-06-12
Bacteriophage composition useful in treating food products to prevent bacterial contamination Grant 6,461,608 - Averback , et al. October 8, 2	2002-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.